Published in J Leukoc Biol on March 14, 2007
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology (2008) 0.97
The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation. Toxicol Sci (2011) 0.96
Mbd2 promotes foxp3 demethylation and T-regulatory-cell function. Mol Cell Biol (2013) 0.92
DNA modifications: function and applications in normal and disease States. Biology (Basel) (2014) 0.88
Plasticity of DNA methylation in mouse T cell activation and differentiation. BMC Mol Biol (2012) 0.86
DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity (2013) 0.84
Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation. Front Genet (2016) 0.80
Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS One (2012) 0.79
Epigenetics, behaviour, and health. Allergy Asthma Clin Immunol (2008) 0.77
DUSP23 is over-expressed and linked to the expression of DNMTs in CD4(+) T cells from systemic lupus erythematosus patients. Clin Exp Immunol (2016) 0.75
Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors. Front Immunol (2016) 0.75
The Mbd4 DNA glycosylase protects mice from inflammation-driven colon cancer and tissue injury. Oncotarget (2016) 0.75
Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4(+) T cells in systemic lupus erythematosus. Clin Epigenetics (2017) 0.75
Translating epigenetics into clinic: focus on lupus. Clin Epigenetics (2017) 0.75
Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum (2012) 2.08
Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther (2009) 1.52
Tacrolimus in the treatment of chronic and refractory late-onset immune-mediated adverse effects related to silicone injections. Dermatol Surg (2011) 1.46
Delayed immune-mediated adverse effects of polyalkylimide dermal fillers: clinical findings and long-term follow-up. Arch Dermatol (2008) 1.41
The neural network as a predictor of cancer in patients with inflammatory myopathies. Arthritis Rheum (2002) 1.40
Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies. Med Clin (Barc) (2009) 1.39
[Neuropsyquiatric manifestations in systemic lupus erythematosus]. Med Clin (Barc) (2009) 1.39
Occupational exposure in patients with the antisynthetase syndrome. Clin Rheumatol (2014) 1.37
Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med (2010) 1.22
Implication of human endogenous retroviruses in the development of autoimmune diseases. Int Rev Immunol (2010) 1.18
Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum (2008) 1.18
Effect of mycophenolate sodium in scleroderma-related interstitial lung disease. Clin Rheumatol (2011) 1.17
DNase 1 and systemic lupus erythematosus. Autoimmun Rev (2008) 1.12
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus. Arthritis Res Ther (2012) 1.09
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev Med Virol (2009) 1.08
Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med (2004) 1.05
DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci (2007) 1.00
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology (2008) 0.97
Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum (2006) 0.94
Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) (2010) 0.92
Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases. Nephrol Dial Transplant (2010) 0.90
Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS One (2012) 0.90
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis (2012) 0.89
Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study. Arthritis Res Ther (2012) 0.89
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum (2011) 0.87
Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy. Muscle Nerve (2007) 0.87
Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol (2009) 0.86
The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev (2008) 0.86
Association of systemic lupus erythematosus clinical features with European population genetic substructure. PLoS One (2011) 0.85
DNase1 activity in systemic lupus erythematosus patients with and without nephropathy. Rheumatol Int (2009) 0.83
Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology (Oxford) (2010) 0.82
Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br J Haematol (2009) 0.82
Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology (2010) 0.82
Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells. Mol Pharm (2013) 0.81
Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol (2013) 0.81
Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg (2009) 0.81
Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. Clin Exp Rheumatol (2013) 0.81
Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) (2009) 0.80
Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation. Blood Cells Mol Dis (2003) 0.80
Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease. Clin Rheumatol (2006) 0.79
DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum (2002) 0.79
Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol (2011) 0.79
Xenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosus. J Clin Immunol (2011) 0.79
Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS One (2012) 0.79
Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients. Rheumatol Int (2014) 0.78
Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol (2014) 0.78
APO2L/TRAIL: new insights in the treatment of autoimmune disorders. Recent Pat Inflamm Allergy Drug Discov (2011) 0.78
Identification of the autoantigen HB as the barrier-to-autointegration factor. J Biol Chem (2003) 0.78
Clinical and serological findings associated with the expression of ITGAL, PRF1, and CD70 in systemic lupus erythematosus. Clin Exp Rheumatol (2013) 0.78
Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study. J Rheumatol (2009) 0.77
Obstructive sleep apnea in patients with inflammatory myopathies. Muscle Nerve (2009) 0.77
Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms. Rheumatol Int (2009) 0.76
[Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population]. Med Clin (Barc) (2002) 0.76
Correlation of ultrasound B-lines with high-resolution computed tomography in antisynthetase syndrome. Clin Exp Rheumatol (2014) 0.76
Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus. Arthritis Res Ther (2014) 0.75
[Clinical features and prognosis of patients with scleroderma renal crisis]. Med Clin (Barc) (2011) 0.75
Epstein-Barr virus-associated lymphoma in patients with dermatomyositis. Be aware of double immunosuppression. Rheumatology (Oxford) (2009) 0.75
Nephrotic syndrome and lambda light-chain monoclonal gammopathy suggestive of primary amyloidosis with positive staining for AA amyloid. J Am Geriatr Soc (2012) 0.75
[Systemic lupus erythematosus and accelerated atheromatosis]. Med Clin (Barc) (2004) 0.75
A 21-year-old girl with recurrent abdominal pain after a robbery. Lancet (2005) 0.75
Enhanced transcript levels of CD48 in CD4⁺ T cells from systemic lupus erythematosus patients. Immunobiology (2011) 0.75
TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells. Nanotechnology (2016) 0.75